The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
 
Jose Manuel Ruiz Morales
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology
 
Marcin Swierkowski
No Relationships to Disclose
 
Connor Wells
No Relationships to Disclose
 
Anna Paola Fraccon
No Relationships to Disclose
 
Francesca La Russa
No Relationships to Disclose
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis; Pfizer
 
Georg A. Bjarnason
No Relationships to Disclose
 
Jae-Lyun Lee
Honoraria - Astellas Pharma; Astellas Pharma; Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Bayer; Exelixis; Janssen; Novartis; Pfizer
 
Hao-Wen Sim
Travel, Accommodations, Expenses - Roche
 
Benoit Beuselinck
No Relationships to Disclose
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Janssen Oncology; Pfizer
 
Takeshi Yuasa
No Relationships to Disclose
 
Carmel Jo Pezaro
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Cezary Szczylik
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer